Experienced in IgG4-Related Disease

Wanruchada Katchamart

1Division Of Rheumatology, 8th Floor Asadang Building, 2 Wanglang Road, 
Bangkok Noi, TH 
Experienced in IgG4-Related Disease
1Division Of Rheumatology, 8th Floor Asadang Building, 2 Wanglang Road, 
Bangkok Noi, TH 
OverviewLocationsClinical Research

Overview

Wanruchada Katchamart practices in Bangkok Noi, Thailand. Katchamart is rated as an Experienced expert by MediFind in the treatment of IgG4-Related Disease. Their top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, COVID-19, and Myositis.

Their clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of IgG4-Related Disease.

Locations

1Division Of Rheumatology, 8th Floor Asadang Building, 2 Wanglang Road, Bangkok Noi, 10700, Thailand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

47 Total Publications

Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in Thailand.
Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in Thailand.
Journal: PloS one
Published: January 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Katchamart's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile